Glimepiride

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 43063-697
  • Package NDC 43063-697-93
  • Application number ANDA077911
  • SPL ID 4d61d452-73b4-4fe1-e063-6394a90aa4b0
  • SPL set ID ed7a3a8e-97dd-4a5a-9497-001acfd2f1f0
  • UNII 6KY687524K
  • RxCUI 199245

What the source publishes

Labeler
PD-Rx Pharmaceuticals, Inc.
Active ingredients
Glimepiride
Form
TABLET
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:43063-697_4d61d452-73b4-4fe1-e063-6394a90aa4b0
{
  "name": "Glimepiride",
  "splId": "4d61d452-73b4-4fe1-e063-6394a90aa4b0",
  "labels": [
    {
      "setId": "ed7a3a8e-97dd-4a5a-9497-001acfd2f1f0",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ed7a3a8e-97dd-4a5a-9497-001acfd2f1f0",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ed7a3a8e-97dd-4a5a-9497-001acfd2f1f0"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "PD-Rx Pharmaceuticals, Inc.",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "180 TABLET in 1 BOTTLE, PLASTIC (43063-697-93)",
      "package_ndc": "43063-697-93",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20160801"
    }
  ],
  "productId": "43063-697_4d61d452-73b4-4fe1-e063-6394a90aa4b0",
  "useDomain": "unknown",
  "dosageForm": "TABLET",
  "productNdc": "43063-697",
  "deaSchedule": null,
  "genericName": "Glimepiride",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "GLIMEPIRIDE",
      "strength": "1 mg/1"
    }
  ],
  "applicationNumber": "ANDA077911",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20120101",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000175608",
      "M0020795"
    ],
    "upc": [
      "0343063697900"
    ],
    "unii": [
      "6KY687524K"
    ],
    "rxcui": [
      "199245"
    ],
    "spl_set_id": [
      "ed7a3a8e-97dd-4a5a-9497-001acfd2f1f0"
    ],
    "pharm_class_cs": [
      "Sulfonylurea Compounds [CS]"
    ],
    "pharm_class_epc": [
      "Sulfonylurea [EPC]"
    ],
    "manufacturer_name": [
      "PD-Rx Pharmaceuticals, Inc."
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:43063-697_4d61d452-73b4-4fe1-e063-6394a90aa4b0"